• Gushengtang agreed on Aug. 27, 2026 to buy 100% of Malaysia-based YC TCM (Taman Segar), YC TCM, SWS Medical.
• Targets run traditional Chinese medicine consultation and treatment services in Malaysia; they will become subsidiaries once the deal closes.
• Deal rationale centers on expanding Gushengtang’s offline clinic network in Malaysia, aiming to lift market share and capture online-offline synergies.
• Purchase price was set via arm’s-length talks, referencing historical performance and prospects; funding planned from placing proceeds, convertible bonds, or idle funds.
• Completion remains conditional on closing requirements under the sale and purchase agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gushengtang Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303113), on August 27, 2026, and is solely responsible for the information contained therein.